CRS logo

Carpenter Technology Corporation (CRS)

$587.77

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CRS

Market cap

$29.20B

EPS

9.5

P/E ratio

45

Price to sales

7.02

Dividend yield

0.136%

Beta

1.24919

Price on CRS

Previous close

$586.47

Today's open

$590.20

Day's range

$581.82 - $597.52

52 week range

$228 - $597.52

Profile about CRS

CEO

Tony R. Thene

Employees

4600

Headquarters

Philadelphia, PA

Exchange

New York Stock Exchange

Shares outstanding

49685612

Issue type

Common Stock

CRS industries and sectors

Industrials

Industrial Goods

News on CRS

Carpenter Technology (CRS) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • Jun 18, 2026

news preview

Supporting the Mission: Catholic Relief Services Chooses Adstra as a Fundraising Partner

PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Adstra Nonprofit today announced a strategic partnership with Catholic Relief Services (CRS), one of the world's leading humanitarian organizations.

news source

GlobeNewsWire • Jun 15, 2026

news preview

Carpenter Technology Corporation (CRS) Hits Fresh High: Is There Still Room to Run?

Carpenter (CRS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

news source

Zacks Investment Research • Jun 10, 2026

news preview

Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon receives US FDA approval for expanded indications of TOFIDENCE, a biosimilar to ACTEMRA, in Cytokine Release Syndrome and Pediatric COVID-19.

news source

Business Wire • Jun 10, 2026

news preview

Why Carpenter Technology (CRS) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

news source

Zacks Investment Research • Jun 8, 2026

news preview

Carpenter Technology (CRS) Is Up 8.03% in One Week: What You Should Know

Does Carpenter Technology (CRS) have what it takes to be a top stock pick for momentum investors? Let's find out.

news source

Zacks Investment Research • Jun 4, 2026

news preview

Carpenter Technology Gains on Record Earnings, Profits

Institutional inflows push Carpenter Technology Corporation (CRS) shares up 1,894% since 2005.

news source

FXEmpire • Jun 3, 2026

news preview

Carpenter (CRS) Upgraded to Buy: Here's Why

Carpenter (CRS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

news source

Zacks Investment Research • Jun 3, 2026

news preview

Before SpaceX IPO, smart investors are buying these 3 stocks

SpaceX is expected to make its Nasdaq debut on June 12 in what could become the largest initial public offering in history. The company is targeting a valuation of about $1.75 trillion, with the proposed ticker SPCX and an unusually large retail allocation.

news source

Invezz • May 29, 2026

news preview

Here's Why Carpenter Technology (CRS) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • May 28, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Carpenter Technology Corporation

Open an M1 investment account to buy and sell Carpenter Technology Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CRS on M1